Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Protection of rhesus macaques against inhalational anthrax with a Bacillus anthracis capsule conjugate vaccine.

Chabot DJ, Ribot WJ, Joyce J, Cook J, Hepler R, Nahas D, Chua J, Friedlander AM.

Vaccine. 2016 Jul 25;34(34):4012-6. doi: 10.1016/j.vaccine.2016.06.031. Epub 2016 Jun 18.

PMID:
27329184
2.

The Madagascar hissing cockroach as a novel surrogate host for Burkholderia pseudomallei, B. mallei and B. thailandensis.

Fisher NA, Ribot WJ, Applefeld W, DeShazer D.

BMC Microbiol. 2012 Jun 22;12:117. doi: 10.1186/1471-2180-12-117.

3.

The cluster 1 type VI secretion system is a major virulence determinant in Burkholderia pseudomallei.

Burtnick MN, Brett PJ, Harding SV, Ngugi SA, Ribot WJ, Chantratita N, Scorpio A, Milne TS, Dean RE, Fritz DL, Peacock SJ, Prior JL, Atkins TP, Deshazer D.

Infect Immun. 2011 Apr;79(4):1512-25. doi: 10.1128/IAI.01218-10. Epub 2011 Feb 7.

4.

In vitro intracellular trafficking of virulence antigen during infection by Yersinia pestis.

DiMezzo TL, Ruthel G, Brueggemann EE, Hines HB, Ribot WJ, Chapman CE, Powell BS, Welkos SL.

PLoS One. 2009 Jul 17;4(7):e6281. doi: 10.1371/journal.pone.0006281.

5.

Burkholderia mallei tssM encodes a putative deubiquitinase that is secreted and expressed inside infected RAW 264.7 murine macrophages.

Shanks J, Burtnick MN, Brett PJ, Waag DM, Spurgers KB, Ribot WJ, Schell MA, Panchal RG, Gherardini FC, Wilkinson KD, Deshazer D.

Infect Immun. 2009 Apr;77(4):1636-48. doi: 10.1128/IAI.01339-08. Epub 2009 Jan 21.

6.

Association of Bacillus anthracis capsule with lethal toxin during experimental infection.

Ezzell JW, Abshire TG, Panchal R, Chabot D, Bavari S, Leffel EK, Purcell B, Friedlander AM, Ribot WJ.

Infect Immun. 2009 Feb;77(2):749-55. doi: 10.1128/IAI.00764-08. Epub 2008 Dec 8.

7.

Activity of the Bacillus anthracis 20 kDa protective antigen component.

Hammamieh R, Ribot WJ, Abshire TG, Jett M, Ezzell J.

BMC Infect Dis. 2008 Sep 22;8:124. doi: 10.1186/1471-2334-8-124.

8.

Treatment of experimental anthrax with recombinant capsule depolymerase.

Scorpio A, Tobery SA, Ribot WJ, Friedlander AM.

Antimicrob Agents Chemother. 2008 Mar;52(3):1014-20. Epub 2007 Dec 26.

9.

Type VI secretion is a major virulence determinant in Burkholderia mallei.

Schell MA, Ulrich RL, Ribot WJ, Brueggemann EE, Hines HB, Chen D, Lipscomb L, Kim HS, Mrázek J, Nierman WC, Deshazer D.

Mol Microbiol. 2007 Jun;64(6):1466-85.

10.

Multiple asparagine deamidation of Bacillus anthracis protective antigen causes charge isoforms whose complexity correlates with reduced biological activity.

Powell BS, Enama JT, Ribot WJ, Webster W, Little S, Hoover T, Adamovicz JJ, Andrews GP.

Proteins. 2007 Aug 1;68(2):458-79.

PMID:
17469195
11.

Anthrax lethal toxin impairs innate immune functions of alveolar macrophages and facilitates Bacillus anthracis survival.

Ribot WJ, Panchal RG, Brittingham KC, Ruthel G, Kenny TA, Lane D, Curry B, Hoover TA, Friedlander AM, Bavari S.

Infect Immun. 2006 Sep;74(9):5029-34.

13.

Comparative vaccine efficacy of different isoforms of recombinant protective antigen against Bacillus anthracis spore challenge in rabbits.

Ribot WJ, Powell BS, Ivins BE, Little SF, Johnson WM, Hoover TA, Norris SL, Adamovicz JJ, Friedlander AM, Andrews GP.

Vaccine. 2006 Apr 24;24(17):3469-76. Epub 2006 Feb 21.

PMID:
16519970
14.

Dendritic cells endocytose Bacillus anthracis spores: implications for anthrax pathogenesis.

Brittingham KC, Ruthel G, Panchal RG, Fuller CL, Ribot WJ, Hoover TA, Young HA, Anderson AO, Bavari S.

J Immunol. 2005 May 1;174(9):5545-52.

15.

Time-lapse confocal imaging of development of Bacillus anthracis in macrophages.

Ruthel G, Ribot WJ, Bavari S, Hoover TA.

J Infect Dis. 2004 Apr 1;189(7):1313-6. Epub 2004 Mar 19.

PMID:
15031802
16.
17.

Supplemental Content

Loading ...
Support Center